International multi-center phase III clinical trial of Contezolid
Latest Information Update: 09 Jun 2021
At a glance
- Drugs Contezolid (Primary)
- Indications Bacterial infections; Skin and soft tissue infections
- Focus Registrational; Therapeutic Use
- 09 Jun 2021 New trial record
- 03 Jun 2021 According to a MicuRx Pharmaceuticals media release, the company plan to initiate this trial to accelerate the approval for contezolid globally.